Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Pneumonitis
ADR ID BADD_A03482
ADR Hierarchy
22      Respiratory, thoracic and mediastinal disorders
22.01      Lower respiratory tract disorders (excl obstruction and infection)
22.01.01      Lower respiratory tract inflammatory and immunologic conditions
22.01.01.006      Pneumonitis
Description A disorder characterized by inflammation focally or diffusely affecting the lung parenchyma. [CTCAE] Infection of the lung often accompanied by inflammation. | Inflammation of any part, segment or lobe, of the lung parenchyma. [MeSH]
MedDRA Code 10035742
MeSH ID D011014; D011014; D011014
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Other pneumonitis due to solids and liquids | Pneumonitis | Pneumonitis due to other solids and liquids | Pneumonitis due to solids and liquids | Pneumonitis NOS | Pulmonitis | Lung inflammation | Pneumonia | Pneumonias | Lobar Pneumonia | Lobar Pneumonias | Pneumonias, Lobar | Pneumonia, Lobar | Experimental Lung Inflammation | Experimental Lung Inflammations | Inflammation, Experimental Lung | Lung Inflammation, Experimental | Lung Inflammations, Experimental | Pneumonitides | Pulmonary Inflammation | Inflammation, Pulmonary | Inflammations, Pulmonary | Pulmonary Inflammations | Lung Inflammation | Inflammation, Lung | Inflammations, Lung | Lung Inflammations
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02344Vemurafenib0.001083%
BADD_D02345Venetoclax0.000799%
BADD_D02346Venlafaxine0.000447%
BADD_D02363Vinorelbine0.000139%
BADD_D02365Vismodegib--
BADD_D02373Warfarin--
BADD_D02412Octreotide0.003921%
BADD_D02414Mesalazine0.001700%
BADD_D02424Valaciclovir0.000241%
BADD_D02443Tiotropium0.000608%
BADD_D02453Midostaurin0.002398%
BADD_D02464Fingolimod--
BADD_D02480Alectinib0.003197%
BADD_D02483Ribociclib0.003197%
BADD_D02486Niraparib0.001066%
BADD_D02498Abemaciclib0.002664%
BADD_D02500Alpelisib0.002398%
BADD_D02504Lorlatinib0.000486%
BADD_D02509Brigatinib0.001598%
BADD_D02520Baloxavir marboxil0.001447%
The 6th Page    First    Pre   6    Total 6 Pages